Document is current
Any future updates will be listed below
-
Authors
Pan, Tuo
Jiang, Chen-Yu
Zhang, He
Han, Xi-Kun
Zhang, Hai-Tao
Jiang, Xin-Yi
Chen, Wei
Wang, Kuo
Fan, Fu-Dong
Pan, Jun
Zhou, Qing
Wang, Chuang-Shi
Zhang, Li
Wang, Dong-Jin
-
Clinical Trials BETA
Clinical trials referenced in this document:
chictr2000040129 at Chinese Clinical Trial RegistryDocuments that mention this clinical trial
The low-dose colchicine in patients after non-CABG cardiac surgery: a randomized controlled trial
https://doi.org/10.1186/s13054-023-04341-9
-
Funding
Funding for this research was provided by:
The clinical medical center of Nanjing cardiovascular disease (CZLB506-2020)
- License Information
-
More Information
Article History
Received: 12 November 2022
Accepted: 31 January 2023
First Online: 7 February 2023
Declarations
:
: The Institutional Review Board of Nanjing Drum Tower Hospital approved the study and protocol (approval number: 2020–293-02). The trial was conducted in accordance with the ethical principles of the “Declaration of Helsinki,” the International Conference on Harmonisation–Good Clinical Practice (ICH-GCP) guideline, the “Quality Management Standards for Drug Clinical Trials” of the Chinese Food and Drug Administration (CFDA), the “Medical Devices Clinical Trial Quality Management Standards” of the CFDA, the “Ethical Review Measures for Biomedical Research Involving Humans” of the National Health Commission of China, and other relevant national laws and regulations. Informed consent by the study participant or a legally authorized representative was given prior to inclusion in the study.
: Not applicable.
: The authors declare that they have no competing interests.
